Stay updated with breaking news from Christophera Herr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced it has entered into a loan facility agreement with Oxford Finance LLC and Silicon Valley Bank for up to $100 million of non-dilutive financing.
31.10.2022 - Expects to extend cash runway to mid-2025SOUTH SAN FRANCISCO, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) - ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 ... Seite 1
Biology-guided radiotherapy (BgRT) technology developer RefleXion Medical announced today that it closed a $125 million debt facility.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced $40 million in venture debt...